PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
6.24
+0.10 (1.63%)
At close: Nov 9, 2026, 4:00 PM EST
6.24
0.00 (0.00%)
Pre-market: Nov 10, 2026, 9:03 AM EST
PolyPid Market Cap
PolyPid has a market cap or net worth of $126.75 million as of November 9, 2026. It is the 23,406th most valuable company in the world and the 3,901st biggest in the United States. Its market cap has increased by 118.43% in one year.
Market Cap
126.75M
Enterprise Value
121.75M
1-Year Change
118.43%
Global Rank
Country Rank
#3,901 United States
Category
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $126.75M, an increase of 53.75%. That is a compound annual growth rate of 6.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 126.75M | 75.56% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 133.79M |
| Jyong Biotech | 133.62M |
| Innate Pharma | 131.22M |
| Armata Pharmaceuticals | 130.51M |
| Humacyte | 124.51M |
| Nkarta | 123.91M |
| Molecular Partners AG | 121.60M |
| Coherus Oncology | 118.97M |